Description
We specialise in developing accurate, scalable, and regulatory-ready Point of Care molecular diagnostic platforms. Whether you're targeting infectious diseases, oncology, genetic disorders, or pharmacogenomics, we provide the complete scientific, technical, and commercial pathway to bring your assay from concept to clinic.